High value care Program Leadership

High Value Care Corporate Steering Committee

Chair

    • Dr. Michael McKenna, EVP / CMO MHC

Members

    • Dr. Dennis Spender, CMO McLaren Laboratory
    • Dr. Brad Ropp, CMO McLaren Medical Group
    • Dr. Sara Liter-Kuester, Cerner Project Physician Lead
    • Dr. Robert Flora, Chief Academic Officer MHC
    • Dr. Binesh Patel, CMO McLaren Flint
    • Dr. Kevin Carter, Chief of Staff McLaren Lapeer
    • Dr. Michael Ziccardi, Medical Director McLaren Physician Practice
    • Dr. Erlene Seymour, Karmanos Cancer Center
    • Dr. Asif Ishaque, Chair, PMC ACO
    • Dr. Tim Hannon, CEO Healthcare Forward
    • Chandan Gupte, VP Clinical Excellence MHC
    • Danette Hayman, Director Corporate Quality MHC
    • Don Henderson, VP McLaren Laboratory
    • Dr. Carlos Rios-Bedoya, Corporate Director of Scholarly Inquiry
    • Bernie Adams, SSBB, Director of Performance Improvement Education


Repetitive Testing Task Force

Co-chairs

    • Dr. Neil Caliman, Pathology Medical Director Greater Lansing
    • Dr. Anil Kumar, Critical Care Medical Director Greater Lansing

Members

    • Dr. Andrew McDonagh, CMO Northern
    • Dr. Binesh Patel, CMO Flint
    • Dr. Tim Hannon, CEO Healthcare Forward
    • Dr. Heather Signorelli, Medical Director Healthcare Forward
    • Chandan Gupte, VP Clinical Excellence and Research
    • Danette Hayman, Corporate Director of Quality
    • Don Henderson, VP McLaren Laboratory


Reference Lab Testing Task Force

Co-chairs

    • Dr. Shane Starr, Pathology Medical Director McLaren Bay Region
    • Dr. Erlene Seymour, Oncologist Karmanos Cancer Center

Members

    • Dr. Paul Swerdlow, Hematologist Karmanos Cancer Center
    • Dr. Tim Hannon, CEO Healthcare Forward
    • Dr. Heather Signorelli, Medical Director Healthcare Forward
    • Chandan Gupte, VP Clinical Excellence and Research
    • Danette Hayman, Corporate Director of Quality
    • Don Henderson, VP McLaren Laboratory

Antimicrobial Stewardship Task Force

Members

  • Dr. Jon Sangeorzan, Infectious Disease McLaren Northern
  • Dr. Dennis Spender, CMO McLaren Labs
  • Dr. Aaron Goldfarb, Pathology Medical Director McLaren Port Huron
  • Dr. Binesh Patel, CMO McLaren Flint
  • Dr. Tim Hannon, CEO Healthcare Forward
  • Dr. Heather Signorelli, Medical Director Healthcare Forward
  • Brian Hatcher, Microbiology Director McLaren Labs
  • Lisa Engles, Epidemiology Coordinator Karmanos Cancer Center
  • Karolina Kaser, Infection Preventionist McLaren Oakland

Imaging Appropriate Use Criteria Task Force

Co-chairs

  • Dr. Kevin Carter, Radiology Medical Director McLaren Oakland
  • Mark Gray, Corporate Director Information Technology

Members

  • Dr. Sara Liter-Kuester, ONE McLaren Physician Lead
  • Dr. Brad Ropp, CMO McLaren Medical Group
  • Dr. Michael Ziccardi, CMO McLaren Physician Partners
  • Dr. Tressa Gardner, Regional Medical Director American Physician Partners
  • Dr. Tim Hannon, CEO Healthcare Forward
  • Chandan Gupte, VP Clinical Excellence and Research
  • Danette Hayman, Corporate Director of Quality
  • Janelle Spann, Director Imaging Services
  • Kimberly Segal, Corporate Manager Revenue Integrity
  • Melissa Benchley, Regional Director Patient Access, McLaren Northern Michigan
  • Kim Chaltry, Director of Medical Imaging Services and Radiation Oncology, McLaren Port Huron
  • Brina Rolison, Quality Improvement Analyst